產(chǎn)品詳情
簡單介紹：
Anti-ATP6V0D2抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-ATP6V0D2抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ATP6V0D2
Cat. Number:
Anti-ATP6V0D2抗體KL-12548R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Vacuolar-type H+-ATPase (V-ATPase) is a multisubunit enzyme responsible for acidification of eukaryotic intracellular organelles. V-ATPases pump protons against an electrochemical gradient, while F-ATPases reverse the process, thereby synthesizing ATP. A peripheral V1 domain, which is responsible for ATP Anti-ATP6V0D2抗體hydrolysis, and a integral V0 domain, which is responsible for proton translocation, compose V-ATPase. Nine subunits (A–H) make up the V1 domain and five subunits (a, d, c, c' and c") make up the V0 domain. Like F-ATPase, V-ATPase most likely operates through a rotary mechanism. V-ATPase D2 is a 350 amino acid protein that is expressed in kidney, lung and osteoclast. V-ATPase D2 has been implicated as a regulator of urine acidification, osteoclast fusion and bone formation. Furthermore, V-ATPase D2 has been identified as a dendritic cell marker.
Also known as:
Anti-ATP6V0D2抗體V-ATPase D2; ATP6D2; ATPase H+ transporting lysosomal 38kDa V0 subunit D; ATPase H+ transporting lysosomal 38kDa V0 subunit D isoform 2; ATPase H+ transporting lysosomal 38kDa V0 subunit D2; FLJ38708; V ATPase subunit d 2; Vacuolar ATP synthase subunit d 2; Vacuolar proton pump subunit d 2; VMA 6; VMA6; VA0D2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ATP6V0D2/V-ATPase D2.
●
Predicted Molecular Weight: 40kDa.
Storage:
Shipped at 4℃, Anti-ATP6V0D2抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Anti-ATP6V0D2抗體Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Anti-ATP6V0D2抗體Optimal working dilutions must be determined by the end user.
kl080Mu01 層粘連蛋白β2(LAMβ2)多克隆抗體 Polyclonal Antibody to Laminin Beta 2 (LAMb2)
kl103Hu01 骨成型蛋白5(BMP5)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 5 (BMP5)
kl103Mu01 骨成型蛋白5(BMP5)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 5 (BMP5)
kl108Mu01 生長分化因子1(GDF1)多克隆抗體 Polyclonal Antibody to Growth Differentiation Factor 1 (GDF1)
kl115Hu01 激活素A受體ⅠB(ACVR1B)多克隆抗體 Polyclonal Antibody to Activin A Receptor Type I B (ACVR1B)
kl115Mu01 激活素A受體ⅠB(ACVR1B)多克隆抗體 Polyclonal Antibody to Activin A Receptor Type I B (ACVR1B)
kl117Mu01 激活素A受體ⅡA(ACVR2A)多克隆抗體 Polyclonal Antibody to Activin A Receptor Type II A (ACVR2A)
kl118Mu01 激活素A受體ⅡB(ACVR2B)多克隆抗體 Polyclonal Antibody to Activin A Receptor Type II B (ACVR2B)
kl118Ra01 激活素A受體ⅡB(ACVR2B)多克隆抗體 Polyclonal Antibody to Activin A Receptor Type II B (ACVR2B)
kl123Mu01 Smad同源物3(Smad3)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 3 (Smad3)
kl130Po01 頭蛋白(NOG)多克隆抗體 Polyclonal Antibody to Noggin (NOG)
kl411Mu01 肘臀蛋白(CUBN)多克隆抗體 Polyclonal Antibody to Cubilin (CUBN)
kl411Ra01 肘臀蛋白(CUBN)多克隆抗體 Polyclonal Antibody to Cubilin (CUBN)
kl451Hu01 上皮細(xì)胞轉(zhuǎn)化序列2(ECT2)多克隆抗體 Polyclonal Antibody to Epithelial Cell Transforming Sequence 2 (ECT2)
kl463Ra01 內(nèi)皮細(xì)胞特異分子1(ESM1)多克隆抗體 Polyclonal Antibody to Endothelial Cell Specific Molecule 1 (ESM1)
kl494Mu01 弗林蛋白酶(FUR)多克隆抗體 Polyclonal Antibody to Furin (FUR)
kl586Mu01 線粒體解偶聯(lián)蛋白2(UCP2)多克隆抗體 Polyclonal Antibody to Uncoupling Protein 2, Mitochondrial (UCP2)
